Breakthrough for Brain Tumors 5K Raises Nearly $900,000

Printer Friendly

May 14, 2012 - Chicago, Illinois

More than 4,500 runners and walkers from 34 states took part in the American Brain Tumor Association’s (ABTA) annual Breakthrough for Brain Tumors 5K Run/Walk on Saturday, May 12. By the morning of the event, proceeds were approaching $900,000, with more funds still coming in.

Proceeds from the event support brain tumor research and a range of services that the ABTA provides for brain tumor patients and their families. Team, individual and general event donations are still being accepted through Saturday, June 30 at the Breakthrough for Brain Tumors website,

The event, which was held at Chicago’s Montrose Harbor, featured a timed, certified 5K run followed by a 5K walk. Teams, comprised of brain tumor patients, family members, friends, and supporters, ranged in size from few as two people to more than 110 people. Some walked side-by-side with their loved ones, some walked in honor of those who could not take part in the event, and others participated in memory of those who had lost their battle against brain tumors.

Val Warner, co-host of ABC7 Chicago’s “Windy City Live,” and 101.9 FM The Mix’s mid-day host Cara Carriveau served as co-emcees for the morning. Ms. Warner participated in the 5K run and presented awards to top fundraising participants. The Chicago Bulls’ Luvabulls kicked off the run and walk with warm-up/dance routines.

The annual Breakthrough for Brain Tumors 5K Run/Walk draws to Chicago thousands of families and friends who have been impacted by a brain tumor diagnosis. The event continues to grow each year, and will expand to New York City this fall.


Founded in 1973, the American Brain Tumor Association (ABTA) was the first national nonprofit organization dedicated solely to brain tumor research. For nearly 40 years, the Chicago-based ABTA has been providing comprehensive resources that support the complex needs of brain tumor patients and caregivers, as well as the critical funding of research in the pursuit of breakthroughs in brain tumor diagnosis, treatment and care. For more information, visit

#  #  #